Parker Waichman LLP Headlines by Topic
Rituxan
Third Rituxan Patient Diagnosed with PML
Oct 26, 2009
| Parker Waichman LLP
A third Rituxan patient has developed a serious and often fatal brain infection called progressive multifocal leukoencephalopathy (PML). ...
Rituxan - PML Link Could Spark FDA Action
Jun 1, 2009
| Parker Waichman LLP
U.S. health regulators are taking a look at the lymphoma drug Rituxan because of its possible association with progressive multifocal...
Study Finds 57 Rituxan Patients Developed PML
May 20, 2009
| Parker Waichman LLP
Patients taking Rituxan may be at risk of developing a serious, and often fatal brain infection called progressive multifocal leukoencephalitis...
Rituxan Treatment for Rheumatoid Arthritis Implicated in Brain Infection
Sep 11, 2008
| Parker Waichman LLP
The labeling for Rituxan is being revised following a report that a patient administered the drug to treat rheumatoid arthritis had died of the brain...
Rituxan Therapy Linked to Fatal Brain Infection
Aug 14, 2007
| Parker Waichman LLP, LLP
Rituxan, a powerful cancer medication, has been linked to a fatal brain infection called progressive multifocal leukoencephalopathy (PML). PML...
Biotech firms' drug is linked to deaths
Dec 19, 2006
| Los Angeles Times
The bestselling medicine for two of the country's biggest biotech drug companies has been further linked to a rare and deadly brain infection, U.S....
Biogen, Genentech issue warning for Rituxan
Dec 19, 2006
| www.cbsmarketwatch.com
Biogen Idec and Genentech have issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked...
Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients
Dec 19, 2006
| www.medpagetodaycom
Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus (SLE) have died of progressive multifocal...
Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy
Dec 19, 2006
| www.medscape.com
The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML)...
Rituxan warning issued by FDA
Dec 19, 2006
| North County Times
Patients treated with Rituxan may be at risk from a rare, fatal brain infection, the U.S. Food and Drug Administration warned Monday. The FDA said...
